The administration of nicotinamide riboside in a mice model of cardiomyopathy, lacking transferrin receptor protein 1 (TfR1) in the heart, has shown to prevent cardiomegaly, mitochondrial respiration, poor cardiac function, and impaired mitophagy (Xu et al. 2015). This evidence concerns the gene TFRC and cardiomyopathy.